Finance

Lists
018680:KOSDAQ
Seoul Pharma Co Ltd
₩1,882.00
+1.18%
(+22.00) 1D
Oct 19, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 018680...
Open
₩1,860
High
₩1,930
Low
₩1,840
Mkt. cap
21.94B
Avg. vol.
5.99K
Volume
5.24K
P/E ratio
12.62
52-wk high
₩3,310
52-wk low
₩1,750
EPS
₩149
Shares outstanding
11.66M
No. of employees
126
Open
₩1,860
High
₩1,930
Low
₩1,840
Mkt. cap
21.94B
Avg. vol.
5.99K
Volume
5.24K
P/E ratio
12.62
52-wk high
₩3,310
52-wk low
₩1,750
EPS
₩149
Shares outstanding
11.66M
No. of employees
126
News stories
From web sources and news partners
About Seoul Pharma Co Ltd
CEO-
Employees126
Founded1976
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.64B
13.61B
12.07B
11.76B
Cost of goods sold
5.60B
5.71B
4.86B
4.59B
Cost of revenue
5.60B
5.71B
4.86B
4.59B
Research and development expenses
-
2.75B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.08B
4.55B
7.39B
7.52B
Operating expense
8.08B
8.12B
7.39B
7.52B
Total operating expenses
13.68B
13.82B
12.25B
12.10B
Operating income
-33.60M
-217.40M
-185.71M
-343.23M
Other non operating income
2.67B
69.61M
48.55M
9.67M
EBT including unusual items
2.63B
-492.98M
-137.16M
-333.56M
EBT excluding unusual items
2.63B
-491.20M
-137.16M
-333.56M
Income tax expense
9.73M
-117.36M
54.79M
-15.86M
Effective tax rate
0.37%
23.81%
-39.94%
4.75%
Other operating expenses
-
-
-
-
Net income
2.62B
-375.62M
-191.95M
-317.70M
Net profit margin
19.24%
-2.76%
-1.59%
-2.70%
Earnings per share
-
-
-
-
Interest and investment income
-
229.41M
-
-
Interest expense
-
-577.30M
-
-
Net interest expenses
-
-347.88M
-
-
Depreciation and amortization charges
-
761.85M
-
-
EBITDA
640.30M
435.79M
483.10M
322.79M
Gain or loss from assets sale
-
1.90M
-
-
AI content may include mistakes. Learn more
Google apps